Drug resistance | Age (median, range) | Gender (male) n (%) | Malignity n (%) | DM n (%) | CKD n (%) | IS n (%) | HIV n (%) | Dead n (%) |
---|---|---|---|---|---|---|---|---|
Fully sensitive (n: 122) | 45.9 (17–87) | 60 (49.2) | 6 (4.9) | 22 (18.0) | 5 (4.1) | 16 (13.1) | 2 (1.6) | 29 (23.8) |
Monoresistance to INH (n: 9) | 35.4 (19–89) | 1 (11.1) | – | 1 (11.1) | 1 (11.1) | 1 (11.1) | 1 (11.1) | 3 (33.3) |
MDR (n: 5) | 37.6 (19–70) | 1 (20.0) | – | 1 (20.0) | – | 1 (20.0) | – | 2 (40.0) |
Other patterns (n: 6) | 43.3 (28–81) | 4 (16.7) | – | – | 1 (16.7) | – | – | 1 (16.7) |
Total (n: 142) | 44.9 (17–89) | 66 (46.5) | 6 (4.2) | 24 (12.7) | 7 (4.9) | 18 (16.9) | 3 (2.1) | 35 (24.6) |